British Journal of Pharmacology · 1985 · 84 citations · 7 references
MedicineOncologyPharmacologyCancer PharmacologyGastrointestinal OncologyPharmacodynamicsChemical CarcinogenesisGastric CancerGastric DiseasesGastrointestinal PharmacologyOncology PharmacologyAcid Secretion InhibitionAntagonist ActivityGastric SecretionGastric Secretory PhysiologyHistamine H2 Receptor AntagonismHistamine-2 Receptor Antagonist TherapyHistamine-mediated SecretionSecretory Mechanisms
The very late occurrence of gastric carcinoids in a life-span carcinogenicity study with loxtidine in the rat might have resulted from continuous achlorhydria induced by this long-acting unsurmountable histamine H2-antagonist. The nature of the anti-secretory activity of loxtidine was compared with that of ranitidine on histamine-induced acid secretion in the perfused stomach preparation of the rat and in the rat isolated gastric mucosa preparation. Ranitidine and loxtidine had qualitatively different inhibitory effects on acid secretion, ranitidine being a competitive antagonist of histamine even at high concentrations, whereas the effect of loxtidine on both preparations was unsurmountable at relatively low concentrations. These results support the hypothesis that the late formation of gastric carcinoids in rats receiving loxtidine is a consequence of persistent achlorhydria caused by unsurmountable blockade of parietal cell H2-receptors.
7
D Poynter, Corinna Pick, Ralph A HARCOURT et al. · Gut · 1985 · 242 citations · Full text
Medicine, Oncology, Pharmacology +16